baber/WOPTO huggingface dataset:
Patent WO-2007041805-A1 (WO)
Inventor: CLARKSON DAVID
IPC: F21S4/00
Filed: 2006-10-13
Abstract: L’invention concerne un moyen d’éclairage allongé (5), c’est-à-dire une lumière de type câble, et ses procédés de fabrication. Le moyen d’éclairage comprend des conducteurs allongés sensiblement parallèles (6a, 6b) s’étendant dans le sens de la longueur et des dispositifs électroluminescents (9) espacés le long de la longueur du moyen d’éclairage et connectés de part et d’autre des conducteurs. Le moyen d’éclairage possède un corps interne allongé (7) avec des évidements (90) logeant les conducteurs. Une partie de chaque conducteur dépasse de l’évidement dans lequel il est logé et cette partie est connectée aux dispositifs électroluminescents, par exemple par brasage. L’ensemble corps interne, conducteurs et dispositifs électroluminescents est gainé dans un revêtement translucide ou transparent externe (10). Le corps interne et le revêtement externe sont de préférence formés par extrusion d’élastomères de silicone. Selon un procédé de fabrication préféré, le corps interne est extrudé avec les conducteurs pour constituer un câble (12), le matériau du corps interne gainant complètement les conducteurs. On arrache ensuite les morceaux (14, 15) dans le sens de la longueur de ce matériau pour exposer les portions de conducteur. Les dispositifs électroluminescents sont ensuite connectés, et l’ensemble résultant est gainé par extrusion du revêtement externe par-dessus celui-ci.
Patent WO-2007048200-A1 (WO)
Title: Matière photoluminescente ayant une rémanence de longue durée
Inventor: BELADAKERE NAGENDRA NAGARAJU
IPC: C09K11/71
Filed: 2006-10-27
Abstract: La présente invention concerne une matière photoluminescente comprenant une composition de type : aL.bM.cAL.dSi.pP.O.fR Formule (I) selon laquelle L est sélectionné entre Na et/ou K ; M est un métal divalent sélectionné parmi un ou plusieurs éléments du groupe constitué de Sr, Ca, Mg et Ba ; Al, Si, P et O représentent leurs éléments respectifs ; R est sélectionné parmi un ou plusieurs activateurs de type éléments des terres rares ; et Selon laquelle les variables a, b, c, d, p et f sont telles que : 0,0 < a < 0,1 ; 0,0 < b < 0,3 ; 0,0 < c < 0,4 ; 0,0 < d < 0,3 ; 0,0 < p < 0,5 ; 0,0 < f < 0,25, à condition qu'au moins l'une des variables d et p soit 0 et qu'au moins l'une des variables a et b soit 0. L'invention concerne également un procédé mettant en jeu un procédé sol-gel de fabrication de la matière photoluminescente. L'invention concerne également l'utilisation de ladite matière photoluminescente dans des produits finaux ressemblant à du verre.
Patent AU-2006216076-A1 (AU)
Title: Traffic signal lamp assembly and method of replacing same
Inventor: WU CHEN-HO
IPC: F21V17/00
Filed: 2006-09-15
Abstract: A method and apparatus for installing a LED lamp module (24) into a light such as a traffic signal light. The LED lamp module includes a plurality of LED's (38) for producing light. The traffic signal light includes a housing (20), a door assembly (18) removably or movably attached to the housing and having an aperture for passing the light, and a securing bracket (36) having a first end (36a) secured to the door assembly and a second end (36b) secured to the LED lamp module, for maintaining an alignment between the door assembly and the LED lamp module.
Patent AU-2006276088-A1 (AU)
Title: Benzimidazoles useful as inhibitors of protein kinases
Inventor: BINCH HAYLEY
IPC: A61K31/551
Filed: 2006-07-21
Abstract: The present invention relates to compounds useful as inhibitors of Aurora, FLT-3, or PDK1 protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the invention.
Patent AU-2006279218-A1 (AU)
Title: Reducing post-operative adhesion formation with intraperitoneal glutamine
Inventor: OBAYAN ADEBOLA O E
IPC: A61M31/00
Filed: 2006-08-11
Abstract: The present disclosure relates to a method of treating or reducing adhesions in the peritoneum of a patient in need thereof. The method includes performing adhesiolysis on one or more adhesions involving the patient's peritoneum and/or one or more tissues or organs in the patient's peritoneal cavity; and administering to the peritoneum or the peritoneal cavity of the patient an effective amount of a composition comprising at least one glutamine source. The glutamine source is selected from one or more of L-glutamine, physiologically acceptable salts of L-glutamine, and dipeptides comprising L-glutamine.
Patent AU-2006321165-A1 (AU)
Title: Use of A3 adenosine receptor agonist in osteoarthritis treatment
Inventor: FISHMAN PNINA
IPC: A61K31/519
Filed: 2006-11-29
Abstract: Provided is an A3 adenosine receptor agonist (A3AR agonist) for the preparation of a pharmaceutical composition for the treatment of a mammal subject having osteoarthritis (OA), as well as to a method for the treatment of OA in a mammal subject, the method includes administering to said subject in need of said treatment an amount of A3AR agonist, the amount being effective to treat or prevent the development of OA. Preferred but not exclusive A3AR agonists in accordance with the present subject matter are IB-MECA and Cl-IB-MECA. The A3AR agonist may be administered in combination with another drug, such as Methotrexate (MTX). Also provided are pharmaceutical compositions for treatment of osteoarthritis including an amount of an A3AR agonist.
Patent WO-2008003130-A1 (WO)
Inventor: PAPANTONIOU KALIOPI
IPC: A61P37/00
Filed: 2007-07-04
Abstract: A method and composition for cleaning and topical treatment of the scalp in psoriasis. The composition includes oli oil and vinegar with optional essential oils. The method includes topical application optionally followed by combing.
Patent AU-2008202838-A1 (AU)
Title: Combination therapy
Inventor: GREWAL IQBAL
IPC: A61P35/00
Filed: 2008-06-26
Abstract: The invention provides for the treatment of diseases or disorders characterized by cells expressing the CD40 membrane glycoprotein. The invention provides methods for the treatment of various diseases or disorders characterized by cells expressing CD40 with a combination of an agent causes the depletion of cells expressing CD40 and a second agent which causes the depletion of cells expressing the CD20 membrane antigen. Pharmaceutical compositions and articles of manufacture such as kits comprising the agents and combinations thereof are also provided.
Patent WO-2010045684-A1 (WO)
Title: Procédé et système de contrôle de résultats cliniques
Inventor: OBERMAIR ANDREAS
IPC: G06Q10/00
Filed: 2009-10-23
Abstract: L'invention concerne un système de contrôle de résultats cliniques comprenant : une base de données d’utilisateurs servant à conserver des informations se rapportant à une pluralité d’utilisateurs ; une base de données de dossiers de patients associée fonctionnellement à la base de données d’utilisateurs et servant à conserver des informations se rapportant à une pluralité de patients, ladite association fonctionnelle comprenant une association de chaque patient à un ou plusieurs utilisateurs et de chaque utilisateur à un ou plusieurs patients ; un module d’analyse de données associé fonctionnellement à la base de données d’utilisateurs et à la base de données de dossiers de patients afin de générer un ou plusieurs rapports ; une interface d’utilisateur associée fonctionnellement à la base de données d’utilisateurs, à la base de données de dossiers de patients et au module d’analyse de données afin d’introduire des informations relatives aux utilisateurs et aux patients et de générer le ou les rapports, au moins un des rapports contenant des informations sur la survie de patients sélectionnés selon des critères prédéterminés ; et les informations de survie étant utilisées pour produire une courbe de survie à l’aide d’un estimateur statistique pouvant agir sur une fonction de survie par une analyse de la survie en fonction de statistiques inférentielles et / ou de test d’hypothèses.
Patent WO-2010096879-A1 (WO)
Title: Seringue de sécurité rétractable comprenant un moyen de joint compressible
Inventor: WALSH ALLAN
IPC: A61M5/32
Filed: 2010-02-26
Abstract: L'invention concerne une seringue de sécurité dans laquelle est intégrée une aiguille rétractable. La seringue comporte un corps, un piston et un ensemble aiguille, le piston étant muni d'un moyen de joint à son extrémité pour assurer une étanchéité entre le piston et le corps de manière à former un réservoir de façon classique. Le moyen de joint peut être comprimé sous l'action d'une charge supplémentaire. Lors d'une première course descendante du piston sous l'action d'une charge normale, sans que la charge supplémentaire soit appliquée, le piston n'entre pas en contact avec l'ensemble aiguille, de sorte que du fluide est ensuite entraîné dans le corps de la seringue par une première course montante. Lors d'une deuxième course descendante après que l'injection a été entièrement réalisée, une charge supplémentaire est appliquée au piston afin de comprimer le joint de telle sorte que l'extrémité du piston avance davantage et entre en contact avec l'ensemble aiguille en vue de la rétraction subséquente de l'ensemble aiguille lors d'une deuxième course montante. Par ce moyen, l'aiguille est ainsi amenée à se rétracter dans le corps de la seringue suite à l'achèvement de l'injection, le joint compressible étant doté de nervures internes de manière à être autostable sous l'action d'une charge normale.
Patent AU-2010231425-A1 (AU)
Title: Tape cassette and tape printer
Inventor: KOSHIRO YAMAGUCHI
IPC: B41J3/407
Filed: 2010-03-26
Abstract: A cassette case 31 of a tape cassette 30 has a roller support hole and a guide hole 47 provided at diagonal positions in a plan view. A first tape spool 40 wound with a heat-sensitive paper tape 55 is disposed within the cassette case 31 in a first area of the cassette case 31 at the rear side of a division line K. The cassette case 31 has a first tape support hole that faces a shaft hole of the first tape spool 40. When the tape cassette 30 is installed in or removed from a cassette housing portion 8 of a tape printer 1, three shafts provided in the cassette housing portion 8 are respectively inserted in the roller support hole, the guide hole 47, and the first tape support hole. The tape cassette 30 is stably guided along the three shafts in an installation/removal direction.
Patent AU-2010232451-A1 (AU)
Title: Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles in free space
Inventor: JOSEPH CIPOLLONE
IPC: A61M16/08
Filed: 2010-04-02
Abstract: A non-invasive ventilation system may include an interface. The interface may include at least one gas delivery jet nozzle adapted to be positioned in free space and aligned to directly deliver ventilation gas into an entrance of a nose. The at least one gas delivery jet nozzle may be connected to a pressurized gas supply. The ventilation gas may entrain ambient air to elevate lung pressure, elevate lung volume, decrease the work of breathing or increase airway pressure, and wherein the ventilation gas is delivered in synchrony with phases of breathing. A support for the at least one gas delivery jet nozzle may be provided. A breath sensor may be in close proximity to the entrance of the nose. A patient may spontaneous breathe ambient air through the nose without being impeded by the interface.
Patent AU-2010238376-A1 (AU)
Title: A cleaner head
Inventor: SCOTT MAGUIRE
IPC: A47L9/00
Filed: 2010-04-01
Abstract: A cleaner head for a cleaning appliance comprises a housing (12), a sole plate (14) for engaging with the floor surface, the sole plate comprising a suction opening (16) through which dirt-bearing air enters the cleaner head, and a flexible annular seal (70) located between the sole plate (14) and the housing (12) to allow the housing (12) to move relative to the sole plate (14) to reduce the force exerted on the sole plate (14) by the housing (12), thereby allowing the sole plate (14) to ride over the floor surface during a cleaning operation. The cleaner head comprises at least one floor engaging support member connected to the housing (12) for restricting the movement of the housing (12) towards the sole plate to prevent the housing (12) from pushing the sole plate (14) against the floor surface.
Patent AU-2010242959-A1 (AU)
Title: Measurement of body fluid volumes
Inventor: MOLITORIS BRUCE A
IPC: A61K49/00
Filed: 2010-04-29
Abstract: The present invention is related generally to measurement of body fluid volumes in an animal subject. The body fluid volumes of interest include extracellular fluid volume (ECFV), total vascular plasma volume (TVPV) and interstitial fluid volume (IFV). The methods are especially beneficial for subjects suffering from renal failure and particularly those undergoing renal dialysis. ECFV can be measured by administering a first molecule which is non-metabolized and permeable to vessel walls of the vascular system wherein the first molecule is distributed within the total vascular space as well as the interstitial space. TVPV can be measured by administering a second molecule which is non-metabolized and impermeable to vessel walls of the vascular system wherein the second molecule is distributed within only the vascular space. IFV can then be calculated using the equation IFV = ECFV - TVPV.
Patent AU-2010257231-A1 (AU)
Title: Collaborative image capture
Inventor: KO ANTHONY HOK TSUNG
IPC: H04N5/225
Filed: 2010-12-15
Abstract: Abstract COLLABORATIVE IMAGE CAPTURE A method (500) of populating a placeholder (e.g., 204) of a document (100) as images are captured by one or more image capture devices (801), is disclosed. A reference image is captured using one of the image capture devices configured to operate in accordance with a first set of capture settings. The reference image is inserted into a placeholder of a document (100). Target characteristics of a subsequent image to be captured are determined using one ) of the image capture devices (801). The target characteristics are determined based on characteristics of the reference image and characteristics of at least one remaining placeholder in the document (100). A second set of capture settings are determined for one or more of the image capture devices based on the determined target characteristics. The second set of capture settings are communicated to at least one of the image capture devices (801) in order 5 to enable the at least one image capture device to capture the subsequent image in accordance with the second set of capture settings. A placeholder of the document is populated with the subsequent image. - 38 - 3219347v 1(97032 1_Final) -3/10801 Capture Device A Device 12 1 RECEIVE 821 - Recommended settings - Captured image 820 - Image metadata Communications Network (Cloud) 921 Hosted on Document Template Serer- -Server/ Server .Database Computer *305 Module 303 Analysis Dcmn E '---Document Engine Server/ Database Document instance 000 Fig. 3 970321_Figures (3 171843_1)
Patent AU-2010260165-A1 (AU)
Title: Mobile communications device user interface
Inventor: FRIEDMAN JONATHAN D
IPC: H04W88/02
Filed: 2010-06-15
Abstract: A mobile communications device user interface is described. In an implementation, a method is implemented by a mobile communications device that includes outputting a user interface having a portion that is configured to accept content. When an option is selected in relation to the portion to initiate a communication and the content includes one or more contacts, the communication is formed that includes the content and is automatically addressed to the one or more contacts.
Patent AU-2010290423-A1 (AU)
Title: Therapeutic agent for mood disorders
Inventor: YAMADA KOJI
IPC: C07D491/052
Filed: 2010-09-02
Abstract: Disclosed is a therapeutic and/or prophylactic agent for mood disorders, which contains a thiazole derivative represented by general formula (I) (wherein R represents an aryl group or the like, and R represents a pyridyl group or the like) or a pharmaceutically acceptable salt thereof as an active ingredient.
Patent AU-2010303670-A1 (AU)
Title: Pyrrolidine GPR40 modulators
Inventor: ELLSWORTH BRUCE A
IPC: A61K31/44
Filed: 2010-10-05
Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
Patent AU-2010312289-A1 (AU)
Title: Inter vial transfer system
Inventor: REYNOLD DAVID L
IPC: A61J1/20
Filed: 2010-10-27
Abstract: A transfer system suitable for medicaments comprising a vial socket (14), a housing (18) having first and second open ends with the first open end being releasably connected to the vial socket (14), a needle hub (16) mounted within the housing (18), a needle having first and second piercing ends (58, 70) mounted in the needle hub (16), a vial (12) having a neck (32) and a body (30), the vial (12) being inserted in the vial socket (14) and being non removably retained therein, a cartridge (20) having a plunger (24) sealing an open end thereof and a septum (82) located at an opposite end of the cartridge (20), and an activation cap (22) for causing the needle to penetrate a septum (34) of the vial (12) and the septum (82) of the cartridge (20) to permit transfer of components therebetween.
Patent AU-2010325264-A1 (AU)
Title: Biologically active food additive for the prophylaxis of osteoporosis diseases
Inventor: ELISTRATOV DMITRIY GENNADJEVICH
IPC: A23L33/00
Filed: 2010-10-21
Abstract: The invention relates to biologically active food additives and is intended for prophylactic activity for conditions associated with osteoporosis. The technical result consists in producing a biologically active food additive which maintains a normal level of testosterone in the body and provides for effective calcium uptake by the body and the retention of this calcium in the bone tissue for a long period of time, which, in turn, promotes the prophylaxis of osteoporosis diseases.
Patent WO-2011130787-A1 (WO)
Title: Procédé d'amélioration de la santé de la peau
Inventor: KEOGH FIONA
IPC: A61K31/375
Filed: 2011-04-20
Abstract: Cette invention concerne des procédés d'amélioration de la santé de la peau consistant à administre par voie orale à un sujet une composition du resvératrol, une proanthaocyanidine, un extrait de peau de grain de raison et de la vitamine C.
Patent WO-2012027796-A1 (WO)
Title: Formule et procédé pour le traitement du bois d'œuvre
Inventor: HUMPHREY DAVID
IPC: B27K3/34
Filed: 2011-09-02
Abstract: La présente invention porte sur une formule et un procédé pour le traitement du bois d'œuvre. La formule comprend un ou plusieurs produits d'imprégnation et un véhicule aqueux. Lorsqu'ils sont combinés, le ou les produits d'imprégnation et l'eau forment une « enveloppe » protectrice de produit(s) d'imprégnation à l'intérieur du bois traité. La présente invention porte aussi sur un procédé d'exécution du traitement du bois qui utilise cette formule, un concentré d'un ou de plusieurs produits d'imprégnation et d'une trousse qui le ou les comprend.
Patent AU-2011201783-A1 (AU)
Title: Subsea control module with removable section having a flat connecting face
Inventor: HARDEV SINGH
IPC: E21B33/038
Filed: 2011-04-19
Abstract: A subsea device is configured to control a subsea well. The subsea device includes a frame; a blowout preventer connected to the frame; a pressure supply line configured to provide a fluid under pressure; and a control module configured to receive the fluid from the pressure supply line and to distribute the fluid to control various functions of the subsea device. The control module includes a fixed part and a removable section. The fixed part has a first base connected to a valve manifold that houses a hydraulic activated valve and the removable section is configured to detachably attach to the fixed part and includes a second base connected to an electrically activated valve. The hydraulic activated valve of the fixed part is configured to be actuated by the electrically activated valve of the removable section when the removable section is mated to the fixed part. Figure 5 80
Patent AU-2011203101-A1 (AU)
Title: Enzymes for starch processing
Inventor: SHIRO FUKUYAMA
IPC: C12P7/06
Filed: 2011-06-24
Abstract: The present invention relates to polypeptides comprising a carbohydrate-binding 5 module amino acid sequence and an alpha-amylase amino acid sequence as well as to the application of such polypeptides.
Patent AU-2011203201-A1 (AU)
Title: Storage Device Divider
Inventor: DE FRANCESCO MARTIN
IPC: B65D5/498
Filed: 2011-06-30
Abstract: Standard Patent Application Storage Device Divider Abstract A divider is provided tailored to the storage device that it is to be inserted into for the purpose of separating the contents of the storage device into separate chambers avoiding the mixture of the contents at a time which is not desired. Fig. 13
Patent AU-2011223278-A1 (AU)
Title: A switch arrangement for an electrical switchgear
Inventor: LAMMERS AREND
IPC: H02B11/12
Filed: 2011-03-01
Abstract: A switch arrangement (1) for an electrical switchgear (2) comprises a terminal arrangement comprising an insulating housing (3) containing a first electrical contact (5) and a second electrical contact (6) which are spaced apart along an axial direction. A breaker (4) is moveable along the axial direction in the housing to a first position. When the breaker (4) is in the first position and closed it electrically connects the first electrical contact (5) and the second electrical contact (6). The housing (3) is split into a plurality of separate sections (3a, 3b) along the axial direction, and wherein at least one of the electrical contacts (5) is in one of the sections (3a) and at least another of the electrical contacts (6) is in another section (3b).
Patent AU-2011231978-A1 (AU)
Title: Prophylaxis of colorectal and gastrointestinal cancer
Inventor: HOUHOU LEILA
IPC: A61K39/395
Filed: 2011-03-23
Abstract: The present disclosure provides methods and compositions useful for preventing gastrointestinal and/or colorectal cancer in animals, including humans, having pre- cancerous adenomatous polyps. The present disclosure provides compositions comprising anti-PG antibodies suitable for use in the methods of the disclosure. The present disclosure also provides methods and compositions useful for monitoring the efficacy of anti-PG treatment in subjects with pre-cancerous polyps.
Patent AU-2011253681-A1 (AU)
Title: Perivascular mesenchymal precursor cell induced blood vessel formation
Inventor: STAN GRONTHOS
IPC: C12N5/071
Filed: 2011-11-24
Abstract: Mesenchymal precursors cells have been isolated from perivascular niches from a range of tissues utilising a perivascular marker. A new mesenchymal precursor cell phenotype is described characterised by the presence of the perivascular marker 3G5, and preferably also alpha smooth muscle actin together with early developmental markers such as STRO-1 and CD146/MUC18. The perivascular mesenchymal precursor cell is shown to induce neovascularisation and improvement in cardiac function. Suitable administration of preparations of the mesenchymal precursor cells are useful for treatment of cardiovascular diseases, cerebrovascular diseases and peripheral vascular diseases.